Critical Care Medicine

The Department of Critical Care Medicine has 26 beds in operation. Its main monitoring and diagnostic/treatment equipment includes: ultrasound machines; oxygen therapy equipment (6 high-flow devices, 2 non-invasive ventilators, 28 invasive ventilators, and 1 transport ventilator); 5 blood purification machines; 1 ECMO system; PiCCO modules; end-tidal carbon dioxide monitoring modules; and other equipment.

At present, the department has 1 chief physician, 4 associate chief physicians, 9 attending physicians, 1 resident physician, 2 respiratory therapists, and 51 nursing staff members at all levels. The department has established 6 subspecialty groups: the Circulatory Critical Care Group, Neurological Critical Care Group, Abdominal Critical Care Group, Blood Purification Group, ECMO Support Group, and Critical Care Ultrasound Group. It can provide a comprehensive range of monitoring, diagnostic, and treatment services for critically ill patients, including various blood purification technologies (continuous renal replacement therapy (CRRT), hemoperfusion and plasma adsorption, plasma exchange, and bilirubin adsorption); respiratory support technologies (all forms of oxygen therapy, including invasive and non-invasive mechanical ventilation and high-flow nasal oxygen therapy, as well as fiberoptic bronchoscopy for examination and treatment); and various hemodynamic monitoring technologies (critical care ultrasound, PiCCO monitoring, and LiDCO), among others. During the past three-plus years, the department has also implemented extracorporeal membrane oxygenation (ECMO), successfully treating more than 40 patients.

On January 5, 2024, department head Director Li Gang initiated the establishment of the Critical Care Medicine Professional Committee of the Chinese Association of Non-Government Medical Institutions and successfully organized its inaugural meeting and first academic forum. In 2025, the department also assisted Xi'an International Medical Center in organizing the second annual academic conference. In addition, it organizes at least two large academic conferences or professional training courses every year, such as: the Basic Training Course on Respiratory Support Technologies (First Session), Peking University International Station; the Circulatory Critical Care Symposium and Construction of an In-Hospital Emergency Care System and Advanced Cardiopulmonary Resuscitation Training Course (ACLS-EP in ICU), Peking University International Station; the Workshop on Clinical Application Skills of Extracorporeal Membrane Oxygenation (ECMO); and the Symposium on Clinical Practice and Technical Applications in Neurological Critical Care. In 2025, using the Association of Non-Government Medical Institutions as a platform, the department applied for and successfully organized the national continuing education project “Circulatory Critical Care Symposium and Construction of an In-Hospital Emergency Care System and Advanced Cardiopulmonary Resuscitation Training Course.”

Research achievements over the past two years include: 9 publications in 2024 (7 SCI-indexed papers and 2 papers in Chinese) and 4 publications in 2025 (2 SCI-indexed papers and 2 papers in Chinese), 1 intramural research project, and 4 new utility model patents.

Our department has established a discipline development objective supported by 6 subspecialty groups and centered on “building one brand and three distinctive strengths” (namely, building one brand: a circulatory critical care brand—a critical care circulatory monitoring, diagnosis, and treatment brand based on bedside critical care ultrasound and invasive hemodynamic monitoring; and creating three distinctive strengths: extracorporeal life support “ECMO,” neurological critical care monitoring, diagnosis, and treatment, and respiratory monitoring, diagnosis, treatment, and support). The objective has been preliminarily achieved, and we will continue to develop sustainably in the future under the guidance of this development plan.